Biological Evaluation and Biomedical Application of Nanoparticles-Based Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Biopharmaceutics".
Deadline for manuscript submissions: closed (10 July 2022) | Viewed by 3797
Special Issue Editors
Interests: nanomedicine; drug delivery; hybrid nanoparticles; liposomes; placental barrier; nasal administration; microfluidics-based nanoparticles production
Interests: nanomedicine; drug delivery; blood brain barriers, placenta models, liposomes and lipoplexes, neurodegenerative diseases; pregnancy disorders
Special Issue Information
Dear Colleagues,
Nanoparticles-based pharmaceutical dosage forms became one of the major research areas in pharmaceutical research. The choice of lipid nanoparticles as a carrier for siRNA and mRNA in a recent marketed drug and vaccines highlights the advancements in production, characterization, and biological evaluation of nanoparticles for therapeutic and diagnostic applications.
Uptake, toxicity, passage through a biological barrier, and biodistribution of nanoparticles are usually evaluated using customized protocols and experimental models. Advanced analytical tools could be also associated with the biological models to get more specific information.
This Special Issue will therefore consider some of the recent studies in the field of biological evaluation and applications of nanomedicines. It is open for studies that describe and discuss an original approach, technical advancement, or new models regarding nanoparticles' evaluation and models validation. Reviews discussing this topic are also welcomed.
Dr. Khair Alhareth
Prof. Dr. Karine Andrieux
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biological models
- liposomes
- nanoparticles
- drug delivery
- siRNA and mRNA delivery
- advanced technologies
- in vitro/in vivo correlation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
